This Doncaster group imports and distributes prescription medicines to more than 4,000 independent pharmacies throughout Britain and Ireland. It was formed in 2013, when managing director Mark Gulliford, 48, and finance director Andy Wilson, 53, led a £37m management buyout of DE Group, Doncaster Pharmaceuticals and Eurodrug from wholesaler Mawdsleys, which retains a 20% stake.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
Year2017
Rank126
CompanyConverse Pharma
ActivityPharmaceuticals distributor
LocationDoncaster
Sales £m187
Operating profit £m4.1
Main shareholdersAndrew Wilson (40%), Mark Gulliford (40%), Mawdsleys Group Investments (20%)
Staff495
Founded2013
Websitewww.conversepharmagroup.com

If applicable:

* supplied by Company   † annualised figure   ‡  profit = ebitda